Essity AB (ESSITY-B.ST) is a Swedish multinational hygiene and health company that operates in the tissue, personal care, and incontinence markets. The company has a strong portfolio of brands including TENA, Tork, and Libero, and benefits from stable demand driven by demographic trends and increasing hygiene awareness.
Investment Thesis: Essity is a classic consumer compounder with pricing power, cost efficiencies, and a strong balance sheet. The company is undergoing a margin improvement program that is expected to drive operating margin expansion from ~12% to 15%+ over the next few years. Additionally, Essity’s focus on sustainability and innovation positions it well for long-term growth in emerging markets.
12-Month Catalysts:
- Continued margin improvement from cost savings and price/mix initiatives.
- Strong free cash flow generation supporting dividend growth and potential share buybacks.
- Expansion in emerging markets, particularly in Asia and Latin America.
Key Risks:
- Raw material cost inflation (pulp, energy) could pressure margins.
- Intense competition from private labels and other global players.
Valuation: Essity trades at ~18x forward P/E, a discount to its historical average and to peers like Kimberly-Clark. With expected EPS growth of 8-10% and a dividend yield of ~3%, the risk/reward is attractive.
Balance Sheet: Essity has a strong investment-grade balance sheet with net debt/EBITDA of ~1.5x and ample liquidity. The company generates robust free cash flow, supporting its capital allocation priorities.
Disclaimer: This is not financial advice. Please do your own research before investing.